Page last updated: 2024-11-05

tetramethylthiourea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID17725
CHEMBL ID12214
CHEBI ID191168
SCHEMBL ID15657
SCHEMBL ID11104551
MeSH IDM0071267

Synonyms (55)

Synonym
AKOS005445484
urea, 1,1,3,3-tetramethyl-2-thio-
nsc102499
thiourea, tetramethyl-
basthioryl
2782-91-4
n,n',n'-tetramethylthiourea
na-101
tmtu
urea,1,3,3-tetramethyl-2-thio-
tetramethylthiourea
nsc-102499
n,n,n',n'-tetramethylthiourea
thiourea, n,n,n',n'-tetramethyl-
inchi=1/c5h12n2s/c1-6(2)5(8)7(3)4/h1-4h
urea,1,1,3,3-tetramethyl,2-thio
nsc 102499
ccris 4871
1,1,3,3-tetramethylthiourea
ai3-28290
tetramethyl-2-thiourea
einecs 220-488-0
urea, thio-, tetramethyl-
hsdb 6777
brn 1744916
STK370053
tetramethylthiourea, 98%
1,1,3,3-tetramethyl-2-thiourea
tetramethyl-thiourea
CHEMBL12214
CHEBI:191168
4-04-00-00232 (beilstein handbook reference)
unii-j6t67a1p72
j6t67a1p72 ,
tmtu, 1,1,3,3-tetramethyl-2-thiourea
FT-0606007
tetramethylthiourea [hsdb]
tetramethyl-2-thiourea, 1,1,3,3-
AB01334043-02
SCHEMBL15657
SCHEMBL11104551
((ch3)2n)2cs
DTXSID5026126
mfcd00008324
tetramethyl thiourea
J-016889
F1285-1701
Q22159079
AS-12238
10.14272/MNOILHPDHOHILI-UHFFFAOYSA-N.1
doi:10.14272/mnoilhpdhohili-uhfffaoysa-n.1
H10721
NCGC00341713-01
CS-0151338
EN300-42417

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
thioureasCompounds of general formula RR'NC(=S)NR''R'''.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 38Homo sapiens (human)EC50 (µMol)100.00000.00491.36102.3000AID1619468
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Taste receptor type 2 member 38Homo sapiens (human)Activity10.00000.15003.256310.0000AID1619467
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
detection of chemical stimulus involved in sensory perception of bitter tasteTaste receptor type 2 member 38Homo sapiens (human)
G protein-coupled receptor signaling pathwayTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityTaste receptor type 2 member 38Homo sapiens (human)
bitter taste receptor activityTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
membraneTaste receptor type 2 member 38Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID71672Percent of untreated control cell growth evaluated in friend leukemia cells on day 3 at a concentration of 2 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
AID71653The degree of erythroid maturation was measured by assessing the proportion of benzidine-positive cells at a concentration of 2 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
AID71664Cell growth of friend erythroleukemia cells measured as percentage of control on day 6 at a concentration of 2 mM1981Journal of medicinal chemistry, Sep, Volume: 24, Issue:9
Cyclic urea and thiourea derivatives as inducers of murine erythroleukemia differentiation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (25.00)18.7374
1990's4 (16.67)18.2507
2000's9 (37.50)29.6817
2010's5 (20.83)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.89 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other25 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]